Rosenberg, G A <br/><br/>
Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury.  [electronic resource] 

 -  Neurology  Jun 1996 
 - 1626-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0028-3878 
<br/><br/><label>Standard No.: </label>10.1212/wnl.46.6.1626  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Anti-Inflammatory Agents--therapeutic use<br/>Autoimmune Diseases--cerebrospinal fluid<br/>Blood-Brain Barrier<br/>Cerebrospinal Fluid Proteins--analysis<br/>Collagenases--cerebrospinal fluid<br/>Gelatinases--cerebrospinal fluid<br/>Glycoproteins--cerebrospinal fluid<br/>Humans<br/>Magnetic Resonance Imaging<br/>Matrix Metalloproteinase 2<br/>Matrix Metalloproteinase 9<br/>Metalloendopeptidases--cerebrospinal fluid<br/>Methylprednisolone--therapeutic use<br/>Multiple Sclerosis--cerebrospinal fluid<br/>Tissue Inhibitor of Metalloproteinases<br/>Urokinase-Type Plasminogen Activator--cerebrospinal fluid